They found that the overexpression of miR-223 decreased the expression of FBXW7 and the sensitivity of GC cells to cisplatin, whereas inhibition of miR-223 restored the expression of FBXW7 and the sensitivity of GC cells to cisplatin (Zhou et al., 2015b). The gene discussed is FBXW7; the disease is gastric cancer.